Pulnovo Medical Announced Results From PADN-CFDA Pivotal Trial
The data from the PADN-CFDA pivotal study meet the primary efficacy and safety endpoint.
January 3, 2022
A Digital Publication for the Practicing Medical Specialist, Industry Executive, & Investor
The data from the PADN-CFDA pivotal study meet the primary efficacy and safety endpoint.